Skip to content
CGT Global Logo
  • About CGT Global
    • About CGT Global
    • Blogs and News
    • Employment
    • Leadership
    • Locations
    • Responsible Sourcing
  • Biospecimens Starting Materials
    • GMP Leukopaks
    • Mobilized Leukopaks
    • RUO Leukopaks
    • Whole Blood
    • Cord Blood
    • Bone Marrow
    • Isolated Cells
    • CellsExpress – Bulk Cell Isolations
  • Clinical Solutions
    • GMP Leukopaks
    • GMP Products
  • Contact Support
    • Contact
    • Request a Quote
    • Technical Support
    • Case Studies
  • How We Help
    • Maternal Blood Donation
    • Donate Blood
    • Locations
    • For Healthcare Partners
    • Research and Development
    • Cell Processing and Isolation
    • Tissue Collection
    • Revolutionizing Cell Therapy Research
Search
Become a Donor
Request a Quote
CGT Global Logo
  • About CGT Global
    • Blog & News
    • Employment
    • Leadership and Board
    • Locations
    • Responsible Sourcing
  • Biospecimens
    • High-Quality Leukopaks: Collected, Processed, and Delivered with Scientific Precision
    • Mobilized Leukopaks
    • GMP Leukopaks Engineered for Clinical Excellence
    • Cord Blood
    • Bone Marrow
    • Whole Blood
    • Isolated Cells
    • Bulk Isolations with CellsExpress
  • Clinical Solutions
    • GMP Leukopaks
    • GMP Cryopreserved Leukopaks
    • GMP Whole Blood
  • Contact
    • Technical Support
    • Case Studies
  • How We Help
    • Maternal Donors
    • Donate
    • Locations
    • For Healthcare Partners
    • Research and Development
    • Cell Processing
    • Tissue Collection
    • Cell Therapy Research
Contact Us

Posts Tagged ‘Drug Development Studies’

Cord Blood CD34+ Cells: High Viability for Humanized Mouse Models

By camerontucker | May 13, 2025
blog cover for cord blood cd34 cells

By: Joanna Wirkus The Rise of Cord Blood CD34+ Cells in Humanized Mouse Models and Cell Therapy Innovation Scientists in the late 1980’s discovered that umbilical cord blood derived stem cells had high proliferative potential and tolerated cryopreservation and thawing (Broxmeyer, 1989). Building on this research, the first report of cord blood derived CD34+ human…

For More Information
Our Products
Healthcare Partners
Bioservices
Applications

Patients & Blood Donors

  • Become a Blood Donor
  • Donation Tips
  • Clinic Locations
  • FAQs

Company

  • Donor Demographics
  • Shipping Options
  • About
  • Case Studies
  • Research & Development Services
  • News / Blog

Contact

  • Quote Requests
  • General Inquiries
  • How to Become a Donor
  • Distributors
  • Technical Support
  • Careers

Terms & Conditions

  • Client Terms and Conditions
  • Client Privacy Policy
  • Product Quality Policy
  • Donor Terms and Conditions
  • Donor Privacy Policy

2025 © CGT GLOBAL. ALL RIGHTS RESERVED.

Call Us: 530-626-7000

5306267000

Contact Our Helpline

  • About CGT Global
    • Blog & News
    • Employment
    • Leadership and Board
    • Locations
    • Responsible Sourcing
  • Biospecimens
    • High-Quality Leukopaks: Collected, Processed, and Delivered with Scientific Precision
    • Mobilized Leukopaks
    • GMP Leukopaks Engineered for Clinical Excellence
    • Cord Blood
    • Bone Marrow
    • Whole Blood
    • Isolated Cells
    • Bulk Isolations with CellsExpress
  • Clinical Solutions
    • GMP Leukopaks
    • GMP Cryopreserved Leukopaks
    • GMP Whole Blood
  • Contact
    • Technical Support
    • Case Studies
  • How We Help
    • Maternal Donors
    • Donate
    • Locations
    • For Healthcare Partners
    • Research and Development
    • Cell Processing
    • Tissue Collection
    • Cell Therapy Research